Strength | 12.5 mg |
Brand | Carmendan |
Manufacturer | RMPL |
Usage/Application | Clinical |
Packaging Type | Vial |
Packaging Size | BOX |
Prescription/Non prescription | Prescription |
Shelf Life | 36 MONTH |
Usage | To treat chronic heart failure. |
Country of Origin | Made in India |
Carmendan Injection belongs to the group of medications called 'calcium sensitizer' primarily used to treat hospitalized patients with acute heart failure. Heart failure can occur when your heart cannot pump blood sufficiently required to the remainder of the body. A heart attack is the blockage of blood flow to the heart muscle. The blockage is most often a build-up of fat, cholesterol, and other substances, which form a plaque in the arteries that feed the heart (coronary arteries). Heart attack and brain stroke can occur simultaneously as the brain's stroke blood supply gets interrupted, causing a part of the brain to die.
Carmendan Injection contains 'levosimendan', which works by increasing the heart's sensitivity to calcium ion (Ca) without increasing the amount of calcium present in the heart's muscles cells. Carmendan Injection widens up the heart's blood vessels (coronary artery) and, in turn, relaxes the smooth muscles of the heart so that blood and oxygen can flow easily to the whole body.
The most common side effects of Carmendan Injection are headache, low blood pressure, and nausea (stomach discomfort). Most of these side effects of Carmendan Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Carmendan Injection should not be given to the patients with low blood pressure (hypotension), dehydration, low blood count, chest pain (angina), or have abnormal heart rhythm. Pregnant or lactating women should consult a doctor before administration of Carmendan Injection. This medicine should not be given to children and adolescents under 18 years of age.
SKU-YCN0PZEBLFJStrength | 12.5 mg |
Brand | Carmendan |
Manufacturer | RMPL |
Usage/Application | Clinical |
Packaging Type | Vial |
Packaging Size | BOX |
Prescription/Non prescription | Prescription |
Shelf Life | 36 MONTH |
Usage | To treat chronic heart failure. |
Country of Origin | Made in India |
Carmendan Injection belongs to the group of medications called 'calcium sensitizer' primarily used to treat hospitalized patients with acute heart failure. Heart failure can occur when your heart cannot pump blood sufficiently required to the remainder of the body. A heart attack is the blockage of blood flow to the heart muscle. The blockage is most often a build-up of fat, cholesterol, and other substances, which form a plaque in the arteries that feed the heart (coronary arteries). Heart attack and brain stroke can occur simultaneously as the brain's stroke blood supply gets interrupted, causing a part of the brain to die.
Carmendan Injection contains 'levosimendan', which works by increasing the heart's sensitivity to calcium ion (Ca) without increasing the amount of calcium present in the heart's muscles cells. Carmendan Injection widens up the heart's blood vessels (coronary artery) and, in turn, relaxes the smooth muscles of the heart so that blood and oxygen can flow easily to the whole body.
The most common side effects of Carmendan Injection are headache, low blood pressure, and nausea (stomach discomfort). Most of these side effects of Carmendan Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Carmendan Injection should not be given to the patients with low blood pressure (hypotension), dehydration, low blood count, chest pain (angina), or have abnormal heart rhythm. Pregnant or lactating women should consult a doctor before administration of Carmendan Injection. This medicine should not be given to children and adolescents under 18 years of age.